eli lilly lawsuit tirzepatide update dropped some massive lawsuits this AM against telehealths offering compound #tirzepatide Eli Lilly sues companies selling

View image online ( Patient holding injectable Use of GLP-1 receptor agonistswith or without glucose-dependent insulinotropic polypeptide (GIP)may be associated with improved clinical outcomes in patients with Type 1 diabetes, according to a large retrospective analysis published in Diabetes Technology & Therapeutics

Anti-Aging Effects

Wegovy and other injectable weight-loss medications have soared in popularity in the past two years

"It's really the Wild West out there," says David Ray, professor of endocrinology and co-director of the Sir Jules Thorn Sleep and Circadian Neuroscience Institute at the University of Oxford

Available at: Accessed 7/5/2012

The GIP component may affect incretin-based medications differently than GLP-1 alone